524703 Stock Overview
Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Sandu Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹61.75 |
| 52 Week High | ₹85.00 |
| 52 Week Low | ₹49.00 |
| Beta | 0.61 |
| 1 Month Change | 8.70% |
| 3 Month Change | -13.64% |
| 1 Year Change | 7.26% |
| 3 Year Change | 39.39% |
| 5 Year Change | 185.88% |
| Change since IPO | 723.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524703 | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | -5.8% | -2.1% | -2.5% |
| 1Y | 7.3% | 0.1% | 44.5% |
Return vs Industry: 524703 exceeded the Indian Personal Products industry which returned -0.2% over the past year.
Return vs Market: 524703 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 524703 volatility | |
|---|---|
| 524703 Average Weekly Movement | 5.8% |
| Personal Products Industry Average Movement | 4.5% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 524703 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524703's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1899 | 323 | Umesh Sandu | sandu.in |
Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally. The company offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. It also provides mahasudarshan kadha, amritarishta, tab.
Sandu Pharmaceuticals Limited Fundamentals Summary
| 524703 fundamental statistics | |
|---|---|
| Market cap | ₹596.57m |
| Earnings (TTM) | ₹11.38m |
| Revenue (TTM) | ₹669.48m |
52.4x
P/E Ratio0.9x
P/S RatioIs 524703 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524703 income statement (TTM) | |
|---|---|
| Revenue | ₹669.48m |
| Cost of Revenue | ₹346.86m |
| Gross Profit | ₹322.62m |
| Other Expenses | ₹311.24m |
| Earnings | ₹11.38m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.18 |
| Gross Margin | 48.19% |
| Net Profit Margin | 1.70% |
| Debt/Equity Ratio | 0% |
How did 524703 perform over the long term?
See historical performance and comparison